Latanoprost and Minoxidil: Comparative Double-Blind, Placebo-Controlled Study for the Treatment of Hair Loss

January 2018 in “ Surgical and Cosmetic Dermatology ”

Leila David Bloch, Cassiano Carlos Escudeiro, Fernanda Daud Sarruf, Neusa Yuriko Sakai Valente

latanoprost minoxidil placebo anagen hair strands hair strand count Rogaine

TLDR Latanoprost and minoxidil effectively control hair loss and increase hair count.

A 180-day double-blind study compared the effectiveness of latanoprost and minoxidil in treating hair loss among 6 groups: placebo, 5% minoxidil, 5% minoxidil + 0.005% latanoprost, 0.005% latanoprost, 5% minoxidil + 0.010% latanoprost, and 0.010% latanoprost. Results showed significant improvement in hair strand count and anagen hair strands for groups treated with 5% minoxidil, 5% minoxidil + 0.005% latanoprost, 0.005% latanoprost, and 5% minoxidil + 0.010% latanoprost. The 0.010% latanoprost group did not show significant differences compared to the placebo. The study concluded that these treatments were effective in controlling hair loss and increasing the total number of hair strands.

View this study on biblat.unam.mx →

Discuss this study in the Community →

Related Research

18 / 18 results

research A Randomized Clinical Trial on Therapeutic Effects of 0.25 mg Oral Minoxidil Tablets on Treatment of Female Pattern Hair Loss

5 citations, September 2021 in “Dermatologic Therapy”

Oral minoxidil effectively treats female pattern hair loss and is a good alternative to topical minoxidil.

Placebo-Controlled Dose-Effect Studies with Topical Minoxidil 2% or 5% in Male-Patterned Hair Loss Treated with Oral Finasteride Employing an Analytical and Exhaustive Study Protocol

research Placebo-Controlled Dose-Effect Studies with Topical Minoxidil 2% or 5% in Male-Patterned Hair Loss Treated with Oral Finasteride Employing an Analytical and Exhaustive Study Protocol

5 citations, January 2020 in “Skin Research and Technology”

Minoxidil 5% works better than 2% for hair growth in male-patterned hair loss.

research Literature Review: Oral Minoxidil for Female Pattern Hair Loss, Topical Finasteride for Treatment of Androgenetic Alopecia, Sulfotransferase Activity Predicts Response to Minoxidil

January 2020 in “Hair transplant forum international”

Oral minoxidil helps female hair loss, topical finasteride treats AGA, and sulfotransferase activity predicts minoxidil effectiveness.

research Comparison of Efficacy of Platelet-Rich Plasma Therapy With or Without Topical 5% Minoxidil in Male-Type Baldness: A Randomized, Double-Blind Placebo Control Trial

26 citations, December 2019 in “Indian Journal of Dermatology, Venereology and Leprology”

PRP combined with minoxidil is the most effective and safe treatment for male pattern baldness.

Efficacy and Safety of a New 5% Minoxidil Formulation in Male Androgenetic Alopecia: A Randomized, Placebo-Controlled, Double-Blind, Noninferiority Study

research Efficacy and Safety of a New 5% Minoxidil Formulation in Male Androgenetic Alopecia: A Randomized, Placebo-Controlled, Double-Blind, Noninferiority Study

5 citations, April 2018 in “Journal of Cosmetic Dermatology”

New 5% minoxidil formula safely and effectively treats male hair loss.

research Minoxidil Dose Response Study in Female Pattern Hair Loss Patients Determined to Be Non-Responders to 5% Topical Minoxidil

1 citations, April 2017 in “Journal of Investigative Dermatology”

Higher minoxidil dose helps hair growth in non-responders without side effects.

research Management of Androgenetic Alopecia: A Comparative Clinical Study Between Plasma Rich in Growth Factors and Topical Minoxidil

8 citations, January 2016 in “European Journal of Plastic Surgery”

PRGF treatment is safer and more effective for hair loss than topical minoxidil.

research Minoxidil 5% Solution for Topical Treatment of Loose Anagen Hair Syndrome

13 citations, March 2014 in “Pediatric Dermatology”

Minoxidil 5% solution significantly improved hair density in a girl with loose anagen hair syndrome over 28 months, with no side effects.

A Randomized Double-Blind Placebo-Controlled Pilot Study to Assess the Efficacy of a 24-Week Topical Treatment by Latanoprost 0.1% on Hair Growth and Pigmentation in Healthy Volunteers with Androgenetic Alopecia

research A Randomized Double-Blind Placebo-Controlled Pilot Study to Assess the Efficacy of a 24-Week Topical Treatment by Latanoprost 0.1% on Hair Growth and Pigmentation in Healthy Volunteers with Androgenetic Alopecia

81 citations, August 2011 in “Journal of The American Academy of Dermatology”

Latanoprost 0.1% may effectively treat hair loss.

Comparison of the Efficacy and Safety of Topical Minoxidil and Topical Alfatradiol in the Treatment of Androgenetic Alopecia in Women

research Comparison of the Efficacy and Safety of Topical Minoxidil and Topical Alfatradiol in the Treatment of Androgenetic Alopecia in Women

56 citations, April 2007 in “Journal der Deutschen Dermatologischen Gesellschaft”

Minoxidil works better for female hair loss than alfatradiol, both safe.

research A Randomized, Placebo-Controlled Trial of 5% and 2% Topical Minoxidil Solutions in the Treatment of Female Pattern Hair Loss

219 citations, March 2004 in “Journal of The American Academy of Dermatology”

5% and 2% minoxidil solutions effectively promote hair growth and reduce hair loss, with 5% being slightly more effective but having more side effects.

research Finasteride Increases Anagen Hair in Men with Androgenetic Alopecia

129 citations, October 2000 in “British Journal of Dermatology”

Finasteride helps increase hair growth in men with hair loss.

Changes in Hair Weight and Hair Count in Men with Androgenetic Alopecia After Application of 5% and 2% Topical Minoxidil, Placebo, or No Treatment

research Changes in Hair Weight and Hair Count in Men with Androgenetic Alopecia After Application of 5% and 2% Topical Minoxidil, Placebo, or No Treatment

115 citations, November 1999 in “Journal of The American Academy of Dermatology”

Minoxidil increases hair weight and count temporarily in men with hair loss.

Quantitative Assessment of 2% Topical Minoxidil in the Treatment of Male Pattern Baldness

research Topical Minoxidil in Early Male Pattern Baldness

138 citations, August 1985 in “Journal of The American Academy of Dermatology”

Minoxidil promotes hair growth in male pattern baldness.

Latanoprost and Minoxidil: Comparative Double-Blind, Placebo-Controlled Study for the Treatment of Hair Loss

Related Community Posts Join

community latanoprost, minoxidil and biotin 3/20/23 vs 5/21/23 same spot

community COMPLETE OVERVIEW of the Treatment of androgenetic alopecia in men

community Cosmo Pharma Lists Breezula Phase 3 Trial on ClinicalTrials.gov